Literature DB >> 22754063

Fluoroquinolone-resistant uncomplicated urinary tract infections, Chinese herbal medicine may provide help.

Yanqing Tong1, Yue Jing, Dongkai Zhao, Liping Zhang, Shiming Zeng.   

Abstract

We assessed the effects of Chinese herbs on the uncomplicated urinary tract infections (UTIs) in women caused by fluoroquinolone-resistant strains. A total of 56 pre-menopausal women with uncomplicated UTIs caused by fluoroquinolone-resistant strains were included. Urine cultures were carried out. All organisms were proved to be fluoroquinolone-resistant at baseline. The patients were orally administrated Chinese herbal concoction for ten days. Chinese herbal concoction eradicated the primary pathogen in 71.4% of the patients at the 1-week follow-up. Among the 20 patients who had bacteriologic failures in the Day 5 of treatment, 2 developed superinfection. Of the failures in the group, Proteus mirabilis, Staphylococcus epidermidis and Providencia rettgeri were implicated in 50.0%, 50.0% and 100.0% of the failures, respectively. The clinical outcomes were also good, with cure or improvement for more than 80% of all subjects. About 14% of the study subjects reported at least one potential adverse event. The adverse events most frequently reported were nausea and diarrhea. All patients tolerated the symptoms. The adverse reactions did not prevail after discontinuation of the medication. Chinese herbal therapy may be an acceptable alternative for the treatment of uncomplicated UTIs caused by fluoroquinolone-resistant uropathogens.

Entities:  

Keywords:  Chinese herbs; Fluoroquinolone-resistant; Urinary tract infection

Mesh:

Substances:

Year:  2011        PMID: 22754063      PMCID: PMC3252729          DOI: 10.4314/ajtcam.v8i5S.18

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  18 in total

1.  Management of uncomplicated urinary tract infections.

Authors:  Timothy Jancel; Vicky Dudas
Journal:  West J Med       Date:  2002-01

2.  Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.

Authors:  Patricia D Brown; Alison Freeman; Betsy Foxman
Journal:  Clin Infect Dis       Date:  2002-03-11       Impact factor: 9.079

3.  Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

Authors:  J W Warren; E Abrutyn; J R Hebel; J R Johnson; A J Schaeffer; W E Stamm
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

4.  The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report.

Authors:  G Kahlmeter
Journal:  J Antimicrob Chemother       Date:  2000-09       Impact factor: 5.790

5.  National patterns in the treatment of urinary tract infections in women by ambulatory care physicians.

Authors:  Elbert S Huang; Randall S Stafford
Journal:  Arch Intern Med       Date:  2002-01-14

6.  Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

Authors:  George G Zhanel; Tamiko L Hisanaga; Nancy M Laing; Melanie R DeCorby; Kim A Nichol; Lorraine P Palatnik; Jack Johnson; Ayman Noreddin; Godfrey K M Harding; Lindsay E Nicolle; Daryl J Hoban
Journal:  Int J Antimicrob Agents       Date:  2005-11       Impact factor: 5.283

7.  Urinary tract infection: self-reported incidence and associated costs.

Authors:  B Foxman; R Barlow; H D'Arcy; B Gillespie; J D Sobel
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

8.  Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.

Authors:  D N Gilbert; S J Kohlhepp; K A Slama; G Grunkemeier; G Lewis; R J Dworkin; S E Slaughter; J E Leggett
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

9.  Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.

Authors:  D F Sahm; I A Critchley; L J Kelly; J A Karlowsky; D C Mayfield; C Thornsberry; Y R Mauriz; J Kahn
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

Review 10.  Emerging mechanisms of fluoroquinolone resistance.

Authors:  D C Hooper
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  5 in total

1.  Prophylactic herbal therapy prevents experimental ascending urinary tract infection in mice.

Authors:  Yan-Qing Tong; Min Sun; Ying Chi
Journal:  Chin J Integr Med       Date:  2016-07-19       Impact factor: 1.978

2.  Chinese herb-resistance and adherence to human uroepithelial cells of uropathogenic Escherichia coli.

Authors:  YanQing Tong; Bing Xin; Ying Chi
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

3.  Virulence genotype and phylogenetic groups in relation to Chinese herb resistance among Escherichia coli from patients with acute pyelonephritis.

Authors:  YanQing Tong; ShuQing Sun; Ying Chi
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

4.  Chinese herbal medicine: a safe alternative therapy for urinary tract infection in patients with renal insufficiency.

Authors:  Yanqing Tong; Yan Leng; Jingli Bai
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-12-29

5.  Transfer of Herb-Resistance Plasmid From Escherichia coli to Staphylococcus aureus Residing in the Human Urinary Tract.

Authors:  Yan Qing Tong; Bing Xin; Li Zhu
Journal:  Jundishapur J Microbiol       Date:  2014-03-01       Impact factor: 0.747

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.